EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-Angiogenic Potential of Marine Streptomyces-Derived Lucknolide A on VEGF/VEGFR2 Signaling in Human Endothelial Cells

Byeoung-Kyu Choi, Min-Hee Jo iD, Hee Jae Shin iD, Sun Joo Park iD

Molecules · 20.02.2025 · 30 (5) · 987

DOI: 10.3390/molecules30050987 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 20.02.2025. Verfasst von Byeoung-Kyu Choi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bio-Convergence Engineering, Dongyang Mirae University, Seoul 08221, Republic of Korea. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor Receptor-2, Angiogenesis Inhibitors, Signal Transduction, Vascular Endothelial Growth Factor A. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Research Foundation (NRF) of Korea, the Korea Institute of Ocean Science and Technology, National Research Foundation (NRF) of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Angiogenesis, primarily driven by the vascular endothelial growth factor (VEGF) and its receptor, the VEGFR, plays a key role in various pathological processes such as cancer progression. Here, we investigated the anti-angiogenic effects of Lucknolide A (LA), a marine Streptomyces-derived compound, and evaluated its potential as a VEGFR2 inhibitor. LA selectively inhibited the proliferation of human endothelial cells EA.hy926 and HUVEC while exhibiting minimal effects on normal fibroblasts and various tumor cells. LA induced S-phase cell cycle arrest and apoptosis in EA.hy926 cells, increasing apoptotic markers p53, Bax, and p21 and decreasing the anti-apoptotic protein Bcl-2, with these effects being further enhanced under VEGF stimulation. Additionally, LA suppressed VEGFR2 phosphorylation and its downstream signaling pathways, including Akt/mTOR/p70S6K, MEK/ERK, Src, FAK, and p38 MAPK, which are crucial for endothelial survival and angiogenesis. Molecular docking studies revealed that LA binds to both inactive (DFG-out, PDB: 4ASD) and active (DFG-in, PDB: 3B8R) VEGFR2 conformations, with a significantly stronger affinity for the active state (−107.96 kcal/mol) than the inactive state (−33.56 kcal/mol), suggesting its potential as a VEGFR2 kinase inhibitor. Functionally, LA significantly inhibited VEGF-induced endothelial migration, tube formation, and microvessel sprouting in both in vitro and ex vivo rat aortic ring assays. Additionally, LA reduced tumor-associated tube formation induced by human breast tumor cells (MDA-MB-231), indicating its potential to suppress VEGF-dependent tumor angiogenesis. These findings suggest that LA is a promising selective anti-angiogenic agent with potential therapeutic applications in angiogenesis-related diseases such as cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor Receptor-2Angiogenesis InhibitorsSignal TransductionVascular Endothelial Growth Factor AStreptomycesEndothelial CellsHumansAnimalsMolecular Docking SimulationCell ProliferationHuman Umbilical Vein Endothelial CellsApoptosisRatsNeovascularization, Pathologic

Stichwörter der Autor:innen

Lucknolide AVEGF/VEGFR2 signalinganti-angiogenesisanti-tumormarine Streptomycesmarine natural compound

Substanzen

Vascular Endothelial Growth Factor Receptor-2Angiogenesis InhibitorsVascular Endothelial Growth Factor AKDR protein, humanVEGFA protein, human

Autor:innen und Institutionen

  • Department of Bio-Convergence Engineering, Dongyang Mirae University, Seoul 08221, Republic of Korea.
  • BB21 Plus Program, Department of Chemistry, Pukyong National University, Busan 48513, Republic of Korea.
  • Marine Natural Products Laboratory, Korea Institute of Ocean Science and Technology, Busan 49111, Republic of Korea.
  • Department of Marine Technology and Convergence Engineering, Korea National University of Science and Technology (UST), Daejeon 34113, Republic of Korea.

ORCID-Profile: Min-Hee Jo, Hee Jae Shin, Sun Joo Park

Förderung

  • the National Research Foundation (NRF) of Korea
  • the Korea Institute of Ocean Science and Technology
  • National Research Foundation (NRF) of Korea
  • Korea Institute of Ocean Science and Technology

Zitieren

APA

Choi, B. K., Jo, M. H., Shin, H. J., & Park, S. J. (2025). Anti-Angiogenic Potential of Marine Streptomyces-Derived Lucknolide A on VEGF/VEGFR2 Signaling in Human Endothelial Cells. Molecules, 30(5), 987. https://doi.org/10.3390/molecules30050987

Vancouver

Choi BK, Jo MH, Shin HJ, Park SJ. Anti-Angiogenic Potential of Marine Streptomyces-Derived Lucknolide A on VEGF/VEGFR2 Signaling in Human Endothelial Cells. Molecules. 2025;30(5):987. doi:10.3390/molecules30050987

BibTeX
@article{Choi2025,
  author = {Choi, Byeoung-Kyu and Jo, Min-Hee and Shin, Hee Jae and Park, Sun Joo},
  title = {Anti-Angiogenic Potential of Marine Streptomyces-Derived Lucknolide A on VEGF/VEGFR2 Signaling in Human Endothelial Cells},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {5},
  pages = {987},
  doi = {10.3390/molecules30050987}
}
Kostenlos starten →